<?xml version="1.0" encoding="UTF-8"?>
<p>Among the 34 BP signature genes (at Bonferroni corrected 
 <italic>p</italic>&lt;0.05), only 
 <italic>FOS</italic> [
 <xref rid="pgen.1005035.ref015" ref-type="bibr">15</xref>] and 
 <italic>PTGS2 [
  <xref rid="pgen.1005035.ref016" ref-type="bibr">16</xref>]
 </italic> have been previously implicated in hypertension. We did not find literature support for a direct role of the remaining signature genes in BP regulation. However, we found several genes involved in biological functions or processes that are highly related to BP, such as cardiovascular disease (
 <italic>GZMB</italic>, 
 <italic>ANXA1</italic>, 
 <italic>TMEM43</italic>, 
 <italic>FOS</italic>, 
 <italic>KCNJ2</italic>, 
 <italic>PTGS2</italic>, and 
 <italic>MCL1</italic>), angiogenesis (
 <italic>VIM</italic> and 
 <italic>TIPARP</italic>), and ion channels (
 <italic>CD97</italic>, 
 <italic>ANXA1</italic>, 
 <italic>S100A10</italic>, 
 <italic>PRF1</italic>, 
 <italic>ANTXR2</italic>, 
 <italic>SLC31A2</italic>, 
 <italic>TIPARP</italic>, and 
 <italic>KCNJ2</italic>). We speculate that these genes may be important for BP regulation, but further experimental validation is needed.
</p>
